Էստոնիա -
էստոներեն -
Ravimiamet
septanest forte süstelahus kolbampullis
septodont - artikaiin+epinefriin (adrenaliin) - süstelahus kolbampullis - 40mg+0,01mg 1ml 1.7ml 50tk
Էստոնիա -
էստոներեն -
Ravimiamet
septolete plus suuõõnesprei, lahus
krka d.d. novo mesto - tsetüülpüridiinkloriid+bensokaiin - suuõõnesprei, lahus - 2mg+10mg 1ml 30ml 1tk
Էստոնիա -
էստոներեն -
Ravimiamet
septolete cherry loseng
krka d.d. novo mesto - tsetüülpüridiinkloriid - loseng - 1,2mg 18tk
Էստոնիա -
էստոներեն -
Ravimiamet
septolete apple loseng
krka d.d. novo mesto - tsetüülpüridiinkloriid - loseng - 1,2mg 18tk
Էստոնիա -
էստոներեն -
Ravimiamet
septolete lemon loseng
krka d.d. novo mesto - tsetüülpüridiinkloriid - loseng - 1,2mg 18tk
Եվրոպական Միություն -
էստոներեն -
EMA (European Medicines Agency)
onivyde pegylated liposomal (previously known as onivyde)
les laboratoires servier - irinotecan anhydrous free-base - pankrease neoplasmid - antineoplastilised ained - metastaatilise ravi, koos 5-fluorouratsiili (5-fu) ja leukovoriiniga (lv), täiskasvanud patsientidel, kelle haigus pärast gemtsitabiini ravi põhineb ravi.
Եվրոպական Միություն -
էստոներեն -
EMA (European Medicines Agency)
filsuvez
amryt pharmaceuticals dac - dry extract from birch bark (der 5-10 : 1), extraction solvent n-heptane 95% (w/w) - epidermolysis bullosa dystrophica; epidermolysis bullosa, junctional - preparaadid haavade ja haavandite raviks - treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa (eb) in patients 6 months and older.
Էստոնիա -
էստոներեն -
Ravimiamet
vetroxy la süstelahus
bimeda animal health limited - oksütetratsükliin - süstelahus - 200mg 1ml 100ml 1tk
Եվրոպական Միություն -
էստոներեն -
EMA (European Medicines Agency)
lonsurf
les laboratoires servier - trifluridine, tipiracil vesinikkloriid - kolorektaalne kasvaja - antineoplastilised ained - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.
Եվրոպական Միություն -
էստոներեն -
EMA (European Medicines Agency)
rapilysin
actavis group ptc ehf - reteplaas - müokardi infarkt - antitrombootilised ained - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.